- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BCLI
Recent news which mentions BCLI
Nasdaq Rises Over 100 Points; Accenture Shares Fall After Q4 Results
September 28, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 28, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 28, 2023
From Benzinga
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 28, 2023
From Benzinga
Crude Oil Moves Lower; CarMax Posts Downbeat Earnings
September 28, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
From Benzinga
Dow Rises 80 Points; US Jobless Claims Edge Higher
September 28, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 28, 2023
From Benzinga
FDA Advisory Panels Gives Thumbs Down To BrainStorm's Lead Therapy
September 28, 2023
Tickers
BCLI
From Benzinga
FDA panel rejects ALS treatment from Brainstorm Cell Therapeutics
September 27, 2023
Tickers
BCLI
Tags
BCLI
From MarketWatch
Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
September 27, 2023
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 26, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
September 25, 2023
From Benzinga
Gold Moves Lower; TransCode Therapeutics Shares Surge
September 25, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 25, 2023
From Benzinga
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
September 25, 2023
From Benzinga
Nasdaq Turns Higher; SCYNEXIS Shares Plunge
September 25, 2023
From Benzinga
Why Is Neurodegenerative Disease-Focused Brainstorm Cell Therapeutics Stock Plunging Today?
September 25, 2023
Tickers
BCLI
From Benzinga
U.S. Stocks Open Lower; Chicago Fed Index Falls In August
September 25, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 25, 2023
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
September 25, 2023
From InvestorPlace
Roth MKM Analyst Projects An Impressive Price Target Of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says "Low Valuation Undeserved"
September 14, 2023
From Benzinga
From Benzinga
BrainStorm Cell Therapeutics Shares Fall After Updated Biomarker Data From Lead Cell Therapy Candidate
July 07, 2023
Tickers
BCLI
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 31, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.